TY - JOUR
T1 - Epidemiological study of gastro-oesophageal reflux disease
T2 - Reflux in spouse as a risk factor
AU - Nasseri-Moghaddam, S.
AU - Mofid, A.
AU - Ghotbi, M. H.
AU - Razjouyan, H.
AU - Nouraie, M.
AU - Ramard, A. R.
AU - Zaer-Rezaie, H.
AU - Habibi, R.
AU - Rafat-Zand, K.
AU - Malekzadeh, R.
PY - 2008/7
Y1 - 2008/7
N2 - Background: Gastro-oesophageal reflux disease (GERD) is a growing health-care problem with variable distribution. Aim: To assess GERD prevalence and risk factors and their possible correlation with pathophysiology in a population-based study. Methods: Individuals aged 18-65 years were enrolled through random cluster sampling in Tehran. Previously validated self-administered questionnaires were used. Results: Of the 2500 questionnaires, 2057 were analysed (mean age: 34.8 ± 13.0 years, 55.1% female). Frequent GERD was seen in 18.2%. Minor symptoms increased prevalence. Female gender (OR: 1.55, 95% CI: 1.01-2.41), BMI >30 kg/m2 (OR: 1.79, 95% CI: 1.03-3.12), less education (OR: 1.52, 95% CI: 1.02-2.27), smoking (OR: 1.83, 95% CI: 1.12-2.99), NSAID use (OR: 4.23, 95% CI: 1.66-10.74) and GERD in spouse (OR: 1.82, 95% CI: 1.18-2.82) were associated with frequent GERD on multivariable analysis. GERD in first-degree relatives (OR: 1.73, 95% CI: 1.23-2.43) and asthma (OR: 4.09, 95% CI: 1.27-13.15) correlated with infrequent GERD. Minor symptoms correlated with GERD history in first-degree relatives, coffee consumption and NSAID use. Prevalence in the past 3 months was similar to that in the past 12 months (P < 0.05). Conclusions: Gastro-oesophageal reflux disease is common in Tehran. The association of 'infrequent symptoms' with GERD history in first-degree relatives and 'frequent symptoms' with GERD history in spouse may point to the presence of yet unknown precipitating environmental factors inducing GERD in a genetically susceptible host. Minor GERD symptoms seem to have independent contribution to GERD. Assessing GERD in the past 3 months predicts prevalence in the past year.
AB - Background: Gastro-oesophageal reflux disease (GERD) is a growing health-care problem with variable distribution. Aim: To assess GERD prevalence and risk factors and their possible correlation with pathophysiology in a population-based study. Methods: Individuals aged 18-65 years were enrolled through random cluster sampling in Tehran. Previously validated self-administered questionnaires were used. Results: Of the 2500 questionnaires, 2057 were analysed (mean age: 34.8 ± 13.0 years, 55.1% female). Frequent GERD was seen in 18.2%. Minor symptoms increased prevalence. Female gender (OR: 1.55, 95% CI: 1.01-2.41), BMI >30 kg/m2 (OR: 1.79, 95% CI: 1.03-3.12), less education (OR: 1.52, 95% CI: 1.02-2.27), smoking (OR: 1.83, 95% CI: 1.12-2.99), NSAID use (OR: 4.23, 95% CI: 1.66-10.74) and GERD in spouse (OR: 1.82, 95% CI: 1.18-2.82) were associated with frequent GERD on multivariable analysis. GERD in first-degree relatives (OR: 1.73, 95% CI: 1.23-2.43) and asthma (OR: 4.09, 95% CI: 1.27-13.15) correlated with infrequent GERD. Minor symptoms correlated with GERD history in first-degree relatives, coffee consumption and NSAID use. Prevalence in the past 3 months was similar to that in the past 12 months (P < 0.05). Conclusions: Gastro-oesophageal reflux disease is common in Tehran. The association of 'infrequent symptoms' with GERD history in first-degree relatives and 'frequent symptoms' with GERD history in spouse may point to the presence of yet unknown precipitating environmental factors inducing GERD in a genetically susceptible host. Minor GERD symptoms seem to have independent contribution to GERD. Assessing GERD in the past 3 months predicts prevalence in the past year.
UR - http://www.scopus.com/inward/record.url?scp=44649084291&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44649084291&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2036.2008.03708.x
DO - 10.1111/j.1365-2036.2008.03708.x
M3 - Article
C2 - 18410559
AN - SCOPUS:44649084291
SN - 0269-2813
VL - 28
SP - 144
EP - 153
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 1
ER -